CellRev, a pioneering spinoff of the University of Newcastle, has developed a scalable technology that boosts yield, reduces costs, and improves quality for biopharmaceuticals and other cellular products. Our innovation combines unique cell detachment reagents with advanced bioprocess design, allowing seamless continuous processing of adherent cells. This is particularly beneficial for applications involving cells that are challenging to adapt or compromise quality when scaled using suspension methods, including Vero cells, iPSCs and cases like certain HEK-293 applications. CellRev's solution marks a significant step forward in enhancing adherent cell processing efficiency and quality.